Detalles de la búsqueda
1.
Polymorphisms in the A118G SNP of the OPRM1 gene produce different experiences of opioids: A human laboratory phenotype-genotype assessment.
Addict Biol
; 29(1): e13355, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38221808
2.
Transplant of organs from donors with positive SARS-CoV-2 nucleic acid testing: A report from the organ procurement and transplantation network ad hoc disease transmission advisory committee.
Transpl Infect Dis
; 25(1): e14013, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36694448
3.
Iteration is not solving the opioid crisis, it's time for transformation.
Am J Drug Alcohol Abuse
; 49(2): 151-158, 2023 03 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36920881
4.
Factors Associated with High-Risk Substance Use in Persons Receiving Psychiatric Treatment for a Primary Trauma- and Stressor-Related Disorder Diagnosis.
J Dual Diagn
; 19(4): 199-208, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37796639
5.
An Evaluation of Evidence Underpinning Management Recommendations in Tobacco Use Disorder Clinical Practice Guidelines.
Nicotine Tob Res
; 24(6): 847-854, 2022 04 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-35023556
6.
Buprenorphine treatment retention and comorbidities among patients with opioid use disorder in a primary care setting.
Am J Addict
; 31(3): 256-260, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35385169
7.
Kratom use as more than a "self-treatment".
Am J Drug Alcohol Abuse
; 48(6): 684-694, 2022 11 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35767669
8.
Need for clarity and context in case reports on kratom use, assessment, and intervention.
Subst Abus
; 43(1): 1221-1224, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35657649
9.
Superlatives in news articles reporting non-FDA approved indications for use of cannabis and cannabis products with a focus on psychiatric disorders: a cross-sectional analysis.
J Ment Health
; 31(1): 109-114, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-34842024
10.
Method for Successfully Inducting Individuals Who Use Illicit Fentanyl Onto Buprenorphine/Naloxone.
Am J Addict
; 30(1): 83-87, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32572978
11.
Evaluation of spin in the abstracts of systematic reviews and meta-analyses focused on treatments of alcohol use disorder.
Am J Drug Alcohol Abuse
; : 1-10, 2021 Apr 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-33900844
12.
Challenges for Women Entering Treatment for Opioid Use Disorder.
Curr Psychiatry Rep
; 22(12): 76, 2020 10 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-33128093
13.
Preliminary evidence of different and clinically meaningful opioid withdrawal phenotypes.
Addict Biol
; 25(1): e12680, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30295400
14.
Non-Opioid Neurotransmitter Systems that Contribute to the Opioid Withdrawal Syndrome: A Review of Preclinical and Human Evidence.
J Pharmacol Exp Ther
; 371(2): 422-452, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31391211
15.
A multiplexed UPLC-MS/MS assay for the simultaneous measurement of urinary safety biomarkers of drug-induced kidney injury and phospholipidosis.
Toxicol Appl Pharmacol
; 366: 54-63, 2019 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30653977
16.
Gabapentin Enacarbil Extended-Release for Alcohol Use Disorder: A Randomized, Double-Blind, Placebo-Controlled, Multisite Trial Assessing Efficacy and Safety.
Alcohol Clin Exp Res
; 43(1): 158-169, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30403402
17.
Randomized comparison of two web-based interventions on immediate and 30-day opioid overdose knowledge in three unique risk groups.
Prev Med
; 128: 105718, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31078564
18.
Individuals with Chronic Pain Who Misuse Prescription Opioids Report Sex-Based Differences in Pain and Opioid Withdrawal.
Pain Med
; 20(10): 1942-1947, 2019 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30690594
19.
Review: Sex-Based Differences in Treatment Outcomes for Persons With Opioid Use Disorder.
Am J Addict
; 28(4): 246-261, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31131505
20.
The Public Health Challenge of Δ8-THC and Derived Psychoactive Cannabis Products.
JAMA
; 331(10): 834-836, 2024 03 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-38470394